Allergy Treatment Market Synopsis

Allergy Treatment Market Size Was Valued at USD 19.80 Billion in 2023, and is Projected to Reach USD 37.1 Billion by 2032, Growing at a CAGR of 6.4% from 2024-2032.

The Allergy Treatment Market can be defined as the vast segment concerned with addressing different kinds of allergic diseases and responses using therapy goods as well as other forms of treatments available in the market. This market comprises antihistamines, corticosteroids, leukotriene modifiers, and biologics all of which are directed to different aspects of the allergic processes. Apart from the drugs, Allergan has the administrative long-term market of immunotherapy, which includes allergy shots and sublingual tablets that help to gradually build up a tolerance to particular allergens. The applications in this market are comprehensive, and they range from respiratory allergies; rhinitis and the asthma type, food allergies, and skin conditions; eczema and dermatitis, respectively. Allergic patients can be treated in many settings, including hospitals and specialized clinics and through homecare and retail pharmacy sales.

• The Allergy Treatment Market is growing at a constant rate, primarily due to a sharp increase in the incidence of allergic diseases. For instance civilisation changes, climatic changes and alteration of some risky aspects of life have led to increased cases of allergies in millions of people across different age and gender divides. This increasing prevalence has encouraged both the patient and health care professionals to keep assessing their ability to effectively manage allergies. Therefore, there is an increasingly thrust for new approaches to managing the disease with advancing treatments including immunotherapy. The market is progressively moving in the direction of more choice and segmentation with simple accessibility over the counter products through to more complex biologic therapies for individual allergies and the patient.
• Furthermore, customers’ awareness about allergies has risen in the past few years, and progress in research technology has sped up the growth of the Allergy Treatment Market. New drug formulation and implementation techniques are improving treatment outcomes and making them available while greater use is being making of personalized medicine, that focuses on grouping patients according to their biochemical characteristics for proper treatment planning. It is also important to mention that at the present the market is actively driven by pharmaceutical companie, healthcare providors, and research institutions all interested in creating of more effective and targeted therapies. In addition, the growth in global population; enhanced healthcare facilities; heightened access to allergy tests and services in newly industrializing nations also act to drive growth. In each case, industry players are gearing themselves to better address a growing need for holistic allergy solutions that enhance the lives of patients living with allergies.

Allergy Treatment Market Trend Analysis

Shift toward Sublingual Immunotherapy (SLIT) Tablets and Drops Boosts Market Development

• Especially, the emergence of sublingual immunotherapy (SLIT) tablets and drops is advancing the market in the allergic treatment segment at a rapid pace. There is interest in SLIT due to better tolerability compared to traditional allergen injection treatments; more patients are speaking to their healthcare providers about this option. SLIT is a non-surgical way of allergen desensitization and patients are prescribed devices that are portable and may be used at home. Some of the benefits include; The program’s simplicity is unique for those who feel anxious around needles or face challenges in getting to specialized hospitals regularly.
• In addition to that, SLIT has been found to be effective in managing different types of allergy such as allergic rhinitis and some food allergies hence making it to be preferred by many patient. The shifting mass of evidence behind its safety and efficacy as well as the approval from authorities have added to the market appeal of SLIT. Manufacturers of pharmaceuticals are also in efforts to meet this requirement through the introduction of likely SLIT products; manufacturers are not only diversifying their products through development of multiformula, multi-dosage SLIT products specific to each patient. As the knowledge about all the benefits of SLIT increases as well as continued campaigns promoting both physicians and patients regarding the technique, the market for sublingual immunotherapy will expand significantly to enhance the treatment of allergic diseases, and ultimately the quality of life of those affected populations.

Rising Allergy Incidence to Drive Demand for Immunotherapy Treatments

• The increasing prevalence of allergies all around the globe has created a huge subsequent demand for immunotherapy accepting a new paradigm of allergy treatment. Allergenic disease which include asthma, allergic rhinitis, and food allergy have significantly been influenced by factors like urbanization, change in environment and change in lifestyles. This situation calls for effectiveness and sustainable treatments to be provided to those affected with the epidemic. Specifically sublingual and injectable immunotherapy can be identified as a new approach to tackle these rising health issues. Different from conventional therapies that simply suppress signs and symptoms of the allergies, immunotherapy tries to alter the immune functions, which offers a long-term cure to people with allergy. Secondly, this has been as a result of increased adoption by individuals both patient and physicians due to their increased perception of immunotherapy as beneficial. If the public gets to learn of the various long-term benefits of desensitization of allergens, then there will be a positive drift towards immunotherapy treatment.
• On the other hand, growing awareness of the disease and more importantly advancement in knowledge and technology has enhanced the safety and effectiveness of immunotherapy hence making it easier for patients to choose. Positive advancement in new immunotherapy products with supportive regulatory frameworks also multiply the market scope within which improved and more options can be availed to suit specific patients’ needs. Thus, the combination of the increasing prevalence of allergy development and the growing usage of immunotherapy can be considered a key component of further advancement in allergy treatment with subsequent enhancement of the latter’s impacts on patient quality of life.

Allergy Treatment Market Segment Analysis:

Allergy Treatment Market Segmented on the basis of type, application and end user.

By Type, Immunotherapy segment is expected to dominate the market during the forecast period

• Segment relied on immunotherapy is expected to hold the largest share in the Allergy Treatment Market due to certain factors. The rise in the incidence of new allergy cases, added the global awareness of the effect of immunotherapy over a longer period is helping to drive this. Immunotherapy is fundamentally different from most other allergy treatments, including antihistamines and corticosteroids that work largely symptomatically while immunotherapy aims at providing the body with immunity against allergens gradually. This approach provides a more plausible solution to people who have a steady allergic health complaint.
• Progress in science and technology has made immunotherapy even more attractive, and various improved and safer approaches have been established, for instance, sublingual Immunotherapy and Injectable Immunotherapy. These innovations are improving patient’s experiences and gaining more approvals and appreciation from the medical professionals. With patients looking for long term solutions to allergy management, immunotherapy is expected to soar and its establishment as one of the defining segment in the market. Being one of the most effective methods capable to alter the existing system of allergy treatment, immunotherapy has bright years ahead.

 By Application, Respiratory Allergies segment expected to held the largest share

• A rapidly growing segment is Respiratory Allergies which should dominate the Allergy Treatment Market due to several factors as will be demonstrated later in the report. Allergic diseases of the respiratory system, especially allergic rhinitis and bronchial asthma, are widespread all over the world and affect millions of people and the quality of their lives. Environmental pollution, awareness of seasonal pollens, dust mite and pet dander have increased the rate of these illnesses requiring better treatments needed to manage these. The growth is also backed up by a large number of specific respiratory allergy therapy such as antihistamines, systemic and topical corticosteroids, leukotriene antagonists and immunotherapy in different forms. In addition, there are other social and awareness created by a global campaign that focus on the necessity of proper prevention and treatment of respiratory diseases have also been instrumental in creating demands for treatments.
• With an awareness of early management of allergies and between the healthcare providers and patients, the concern of respiratory allergies is on extension. Significant advancements in the treatment strategies like targeted biologics and latest immunotherapy are increasing the treatment options efficiency and safety of available treatments which are more attractive to the patients. In particular, the ever-increasing rate of respiratory allergies in people living in urban environments confirms the need for dealing with these ailments, which in turn strengthens the leadership of the segment of respiratory allergies in the market. In line with the increasing knowledge and availability of treatment solutions for allergy this segment is expected to grow significantly and therefore highlights the importance of an effective allergy solution in addressing respiratory disorders.

Allergy Treatment Market Regional Insights:

North America is expected to dominate the Market over the Forecast period

• North America is anticipated to lead throughout the forecast time indicating the consistent dominance that can be credited to specific driving aspects. The region is having a very high incidence rate of allergic disorders such as asthma, allergic rhinitis, and food allergies, thus resulting in high demand for remedies. Highly developed healthcare sector in the country coupled with high end research & development possibilities has ensured a swift entry of new therapies such as immunotherapies and biologics. Moreover, growing consciousness in patients and healthcare facilities as well as a higher willingness to opt for an allergic patient’s treatment owing to the rising awareness levels are also contributing to market progression. Other factors that attribute to the domination of North America can be traced to existence of key pharmaceutical firms that spend much in terms of research and marketing new anti allergy products.
• Bureaus, for example, the FDA is very important in the provision of such treatments hence boosting confidence of patients in search of newer treatments. Further, wider flexibility in terms of health insurance also plays a part in increasing the access of the patients and directing them towards achieving better points of managing allergies in the region. This dynamic of high prevalence rates, novel therapeutic solutions, robust healthcare infrastructure as well as adamant patient awareness puts North America as one of the major contender for the Allergy Treatment Market in the future.

Active Key Players in the Allergy Treatment Market

• Aimmune Therapeutics, Inc. (USA)
• Allergan (a subsidiary of AbbVie) (USA)
• Amgen Inc. (USA)
• AstraZeneca (Sweden)
• Bayer AG (Germany)
• Boehringer Ingelheim (Germany)
• CSL Limited (Australia)
• Dutch Allergy Group (Netherlands)
• GSK (GlaxoSmithKline) (USA)
• Johnson & Johnson (USA)
• Merck & Co., Inc. (USA)
• Novartis International AG (Switzerland)
• Pfizer Inc. (USA)
• Sanofi S.A. (France)
• Stallergenes Greer (France)
• Takeda Pharmaceutical Company (Japan)
• UCB S.A. (Belgium)
• Other key Players

Key Industry Developments in the Allergy Treatment Market:

• In January 2024 several companies have announced breakthroughs in sublingual immunotherapy (SLIT) formulations, with a focus on enhancing effectiveness and patient convenience. These developments aim to provide more user-friendly options that can be administered at home.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Allergy Treatment Market by Type
 4.1 Allergy Treatment Market Snapshot and Growth Engine
 4.2 Allergy Treatment Market Overview
 4.3 Antihistamines
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Antihistamines: Geographic Segmentation Analysis
 4.4 Corticosteroids
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Corticosteroids: Geographic Segmentation Analysis
 4.5 Leukotriene Modifiers
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Leukotriene Modifiers: Geographic Segmentation Analysis
 4.6 Immunotherapy
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Immunotherapy: Geographic Segmentation Analysis
 4.7 Biologics
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 Biologics: Geographic Segmentation Analysis

Chapter 5: Allergy Treatment Market by Application
 5.1 Allergy Treatment Market Snapshot and Growth Engine
 5.2 Allergy Treatment Market Overview
 5.3 Respiratory Allergies
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Respiratory Allergies: Geographic Segmentation Analysis
 5.4 Food Allergies
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Food Allergies: Geographic Segmentation Analysis
 5.5 Skin Allergies
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Skin Allergies: Geographic Segmentation Analysis

Chapter 6: Allergy Treatment Market by End-User
 6.1 Allergy Treatment Market Snapshot and Growth Engine
 6.2 Allergy Treatment Market Overview
 6.3 Hospitals
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospitals: Geographic Segmentation Analysis
 6.4 Clinics
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Clinics: Geographic Segmentation Analysis
 6.5 Homecare Settings
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Homecare Settings: Geographic Segmentation Analysis
 6.6 Pharmacies
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Pharmacies: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Allergy Treatment Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 AIMMUNE THERAPEUTICS INC (USA)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 ALLERGAN (A SUBSIDIARY OF ABBVIE) (USA)
 7.4 AMGEN INC (USA)
 7.5 ASTRAZENECA (SWEDEN)
 7.6 BAYER AG (GERMANY)
 7.7 BOEHRINGER INGELHEIM (GERMANY)
 7.8 CSL LIMITED (AUSTRALIA)
 7.9 DUTCH ALLERGY GROUP (NETHERLANDS)
 7.10 GSK (GLAXOSMITHKLINE) (USA)
 7.11 JOHNSON & JOHNSON (USA)
 7.12 MERCK & CO INC (USA)
 7.13 NOVARTIS INTERNATIONAL AG (SWITZERLAND)
 7.14 PFIZER INC (USA)
 7.15 SANOFI S A (FRANCE)
 7.16 STALLERGENES GREER (FRANCE)
 7.17 TAKEDA PHARMACEUTICAL COMPANY (JAPAN)
 7.18 UCB S A (BELGIUM)
 7.19 OTHER ACTIVE PLAYERS

Chapter 8: Global Allergy Treatment Market By Region
 8.1 Overview
 8.2. North America Allergy Treatment Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Type
  8.2.4.1 Antihistamines
  8.2.4.2 Corticosteroids
  8.2.4.3 Leukotriene Modifiers
  8.2.4.4 Immunotherapy
  8.2.4.5 Biologics
  8.2.5 Historic and Forecasted Market Size By Application
  8.2.5.1 Respiratory Allergies
  8.2.5.2 Food Allergies
  8.2.5.3 Skin Allergies
  8.2.6 Historic and Forecasted Market Size By End-User
  8.2.6.1 Hospitals
  8.2.6.2 Clinics
  8.2.6.3 Homecare Settings
  8.2.6.4 Pharmacies
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Allergy Treatment Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Type
  8.3.4.1 Antihistamines
  8.3.4.2 Corticosteroids
  8.3.4.3 Leukotriene Modifiers
  8.3.4.4 Immunotherapy
  8.3.4.5 Biologics
  8.3.5 Historic and Forecasted Market Size By Application
  8.3.5.1 Respiratory Allergies
  8.3.5.2 Food Allergies
  8.3.5.3 Skin Allergies
  8.3.6 Historic and Forecasted Market Size By End-User
  8.3.6.1 Hospitals
  8.3.6.2 Clinics
  8.3.6.3 Homecare Settings
  8.3.6.4 Pharmacies
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Allergy Treatment Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Type
  8.4.4.1 Antihistamines
  8.4.4.2 Corticosteroids
  8.4.4.3 Leukotriene Modifiers
  8.4.4.4 Immunotherapy
  8.4.4.5 Biologics
  8.4.5 Historic and Forecasted Market Size By Application
  8.4.5.1 Respiratory Allergies
  8.4.5.2 Food Allergies
  8.4.5.3 Skin Allergies
  8.4.6 Historic and Forecasted Market Size By End-User
  8.4.6.1 Hospitals
  8.4.6.2 Clinics
  8.4.6.3 Homecare Settings
  8.4.6.4 Pharmacies
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Allergy Treatment Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Type
  8.5.4.1 Antihistamines
  8.5.4.2 Corticosteroids
  8.5.4.3 Leukotriene Modifiers
  8.5.4.4 Immunotherapy
  8.5.4.5 Biologics
  8.5.5 Historic and Forecasted Market Size By Application
  8.5.5.1 Respiratory Allergies
  8.5.5.2 Food Allergies
  8.5.5.3 Skin Allergies
  8.5.6 Historic and Forecasted Market Size By End-User
  8.5.6.1 Hospitals
  8.5.6.2 Clinics
  8.5.6.3 Homecare Settings
  8.5.6.4 Pharmacies
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Allergy Treatment Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Type
  8.6.4.1 Antihistamines
  8.6.4.2 Corticosteroids
  8.6.4.3 Leukotriene Modifiers
  8.6.4.4 Immunotherapy
  8.6.4.5 Biologics
  8.6.5 Historic and Forecasted Market Size By Application
  8.6.5.1 Respiratory Allergies
  8.6.5.2 Food Allergies
  8.6.5.3 Skin Allergies
  8.6.6 Historic and Forecasted Market Size By End-User
  8.6.6.1 Hospitals
  8.6.6.2 Clinics
  8.6.6.3 Homecare Settings
  8.6.6.4 Pharmacies
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Allergy Treatment Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Type
  8.7.4.1 Antihistamines
  8.7.4.2 Corticosteroids
  8.7.4.3 Leukotriene Modifiers
  8.7.4.4 Immunotherapy
  8.7.4.5 Biologics
  8.7.5 Historic and Forecasted Market Size By Application
  8.7.5.1 Respiratory Allergies
  8.7.5.2 Food Allergies
  8.7.5.3 Skin Allergies
  8.7.6 Historic and Forecasted Market Size By End-User
  8.7.6.1 Hospitals
  8.7.6.2 Clinics
  8.7.6.3 Homecare Settings
  8.7.6.4 Pharmacies
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research